Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treate (Q44454026)
Jump to navigation
Jump to search
scientific article published in June 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treate |
scientific article published in June 2003 |
Statements
1 reference
Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treate (English)
1 reference
Jane T Hickok
1 reference
Joseph A Roscoe
1 reference
Gary R Morrow
1 reference
David K King
1 reference
James N Atkins
1 reference
Tom R Fitch
1 reference
1 June 2003
1 reference
Identifiers
1 reference